Cboe Q4 revenue, EPS up on record volumes

Reuters
02/06
Cboe Q4 revenue, EPS up on record volumes

Overview

  • Derivatives exchange's Q4 net revenue rose 28% yr/yr

  • Adjusted EPS for Q4 grew 46% yr/yr

  • Company sets 2026 organic revenue growth target of mid single-digit

Outlook

  • Cboe expects 2026 organic total net revenue growth in mid single-digit range

  • Company anticipates 2026 Data Vantage organic net revenue growth of mid to high single-digit

  • Cboe sets 2026 adjusted operating expense guidance at $864 to $879 mln

Result Drivers

  • DERIVATIVES VOLUME - Record volumes in index and multi-listed options drove 38% net revenue growth in derivatives business

  • CASH AND SPOT MARKETS - Cash and Spot Markets net revenue rose 27% yr/yr

  • DATA VANTAGE - Data Vantage net revenue increased 9% yr/yr

Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q4 Revenue

$671.10 mln

Q4 Adjusted EPS

$3.06

Q4 EPS

$2.97

Q4 Net Income

$313.50 mln

Q4 Adjusted EBITDA

$464.70 mln

Q4 Adjusted EBITDA Margin

69.20%

Q4 Operating Income

$403.80 mln

Q4 Operating Margin

60.20%

Analyst Coverage

  • The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 4 "strong buy" or "buy", 10 "hold" and 3 "sell" or "strong sell"

  • The average consensus recommendation for the financial & commodity market operators & service providers peer group is "buy."

  • Wall Street's median 12-month price target for CBOE Global Markets Inc is $280.00, about 1.8% above its February 5 closing price of $275.03

  • The stock recently traded at 25 times the next 12-month earnings vs. a P/E of 23 three months ago

Press Release: ID:nPn402FTa

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10